JPIAMR is launching an international call for projects under the umbrella of the JPIAMR and within the framework of the ERA-NET JPIAMR-ACTION.
The call “One Health interventions to prevent or reduce the development and transmission of AMR”, with financial support from the European Commission, includes 30 funding organisations from 21 JPIAMR member countries. The total estimated call budget is 24.9 million Euro.
The call advocates for a One Health approach to understand the impact of interventions on the development and transmission of antibiotic resistance and to design, implement, evaluate, and compare interventions that will have a true impact on preventing or reducing the development and transmission of antibiotic resistance in and between the different One Health settings (human, animal, environment).
The call will support research projects that also have the potential for impact in areas where the risk and burden of AMR is greatest, such as in Low- and middle-income countries (LMICs).
More information on the upcoming call “One Health interventions to prevent or reduce the development and transmission of AMR”, including a partner search tool is now available.
Pre-announcement: One Health interventions to prevent or reduce the development and transmission of AMR
Early 2021 an international call for projects will be launched under the umbrella of the JPIAMR and within the framework of the ERA-NET JPIAMR-ACTION. The call, that will receive financial support from the European Commission, will include 30 funding organisations from 21 JPIAMR member countries. Proposals will be evaluated in a two-step procedure (pre-proposals/full proposals). The call will be launched on January 14th, 2021 and applicants will have up to March 16th, 2021, 12:00 (CET) to submit their pre-proposals.
A match-making partner search tool has been created for applicants, to facilitate networking and the creation of consortia.
Seven networks have been recommended for funding within the JPIAMR 10th transnational call: “JPIAMR Network Plus 2020”.
Seven networks including 146 partners from 35 countries have been recommended for funding within the JPIAMR 10th transnational call: “JPIAMR Network Plus 2020”. The total funding amount is approx. 737.000 €.
The call was launched in February 2020 and supported by research-funding organisations from eight JPIAMR member countries.
The intent of the call was to support networks to design and implement ways to support AMR research considering at least one of the six strategic areas of the JPIAMR Strategic Research and Innovation Agenda (SRIA): Therapeutics, Diagnostics, Surveillance, Transmission, Environment and Interventions. Networks should develop and implement activities focusing on AMR within the domains of Human health, Animal health and the Environment. The Networks were encouraged to bridge multiple One Health areas as needed and to consider the incorporation of their activities within the JPIAMR-Virtual Research Institute (JPIAMR-VRI).
We are happy to share the report of the recent online workshop entitled “Interventions to Reduce the Development and Transmission of AMR”. The workshop was hosted by The French National Research Agency (ANR), in close colla
We are happy to share the report of the recent online workshop hosted by The French National Research Agency (ANR).
We are happy to share the report of the recent online workshop entitled “Interventions to Reduce the Development and Transmission of AMR”. The workshop was hosted by The French National Research Agency (ANR), in close collaboration with JPIAMR. Please find the full report here.
Networks working on AMR in the context of viral-bacterial co-infections, including those working with Covid-19, are eligible to apply for the call.
The intent of the call “JPIAMR Network Plus 2020” is to support networks to design and implement ways to support AMR research considering at least one of the six strategic areas of the JPIAMR Strategic Research and Innovation Agenda: Therapeutics, Diagnostics, Surveillance, Transmission, Environment and Interventions. Networks should develop and implement activities focusing on AMR within the domains of Human health, Animal health and the Environment. Networks working on AMR in the context of viral-bacterial co-infections, including those working with Covid-19, are eligible to apply for the call.
The tenth JPIAMR joint call for transnational networks is in partnership with seven JPIAMR member countries; Canada, France, Italy, Latvia, Norway, Spain, and Sweden. The deadline for submission of applications is May 28th, 17.00 CET. Read more here.
We want to highlight this summers EU Council Conclusions (through the EU Ministers of Health) that reaffirms the challenge of AMR as a top priority for the EU. The Conclusions indicate that EU Member States should be supported in their efforts to combat AMR, but they also need to do more at national level. The Council agrees that the European Commission and EU Member States should further support JPIAMR efforts:
“The Council notes with great concern the market failure in antibiotic development and underlines the need for urgent action to stimulate the development of new antimicrobials, alternative therapies and rapid and modern diagnostics, including methods for antimicrobial susceptibility testing. EU and global coordination and cooperation on research programmes and incentives are needed, and the Council recognises, inter alia, the proposals and activities of the ‘Antimicrobial Resistance Review team’, the ‘Breaking Through the Wall’ report and the ‘Joint Programming Initiative on Antimicrobial Resistance’.” (see p.8)
“Calls upon Member States and the Commission to: Boost research, development and innovation related to AMR, and support EU and global coordination and cooperation including activities through the Joint Programming Initiative on Antimicrobial Resistance and the Global AMR R&D Hub. (see p. 12)”
On June 5-7, 2019, the regional JPIAMR workshop Experiences and Areas of Interest for Strengthening Antimicrobial Resistance Networks was held at the Science Cultural Centre in Buenos Aires, Argentina. The workshop had excellent results in terms of attendance, subjects covered and impact on national, regional and global AMR networks and groups.
Next steps and activities:
Information sessions (INFODAYS) will be held throughout the year for researchers and other stakeholders about JPIAMR and H2020 calls on this subject that are open to third countries.
In line with the conversations held between producers and other AMR players, further joint meetings and activities will be held to identify the problems faced by everyone on this issue.
Participation in all AMR dissemination and awareness activities through the available internal and external channels. Likewise, world awareness days, such as the World Microbiome Day on 27 June, will be taken advantage of by publishing posts and articles on AMR.
Joint activities with other areas of government will be planned, to present AMR efforts in dissemination fairs with great geographic coverage, such as TECNÓPOLIS and TECNÓPOLIS FEDERAL, and other activities achieved through the Linkage area.
On May 28 in Geneva, JPIAMR participated at the Global AMR R&D Hub workshop on “AMR R&D investments”. The objective was to identify and discuss opportunities for investments and new and innovative financing mechanisms for AMR R&D using a global One Health approach. It aimed at providing recommendations on how the Global AMR R&D Hub can support those activities. JPIAMR’s Laura Marin presented in one of the sessions about AMR investments and the JPIAMR AMR Research Funding Dashboard.
The Call on Diagnostics and Surveillance 2019 will fund joint transnational research projects addressing the development of diagnostic and surveillance tools, technologies and methods to detect antimicrobial resistance (AMR). Projects should address the diagnosis of AMR infections in clinical and veterinary settings, or the surveillance of AMR in humans, animals and the environment. The call promotes projects with impact in low and middle income countries (LMICs) in Asia and Africa.
AMR has become one of the major global health and development challenges of the 21st century. The threat of AMR is particularly high in resource-limited and high-risk settings. This is linked to issues such as weak human and animal health systems; diverse means of food production, processing and consumption; food safety and food security; water, hygiene and sanitation challenges; and the global movement of people and goods.
In response to these challenges, the JPIAMR is pleased to launch this joint transnational call for proposals for innovative research projects on new or improved diagnostic and surveillance strategies, tools, technologies and methods. The call will support research projects that also have the potential for impact in areas where the risk and burden of AMR is greatest, such as in LMIC settings in Asia and Africa. Projects are encouraged to use a One Health approach where relevant.
The total call budget is approx. 20 million Euro.
For full information about the call and the application process, please visit the call page.
The two-step application process (pre-proposal, full proposal) will have the following targeted timetable:
November 15 2018
Preannouncement: Antibiotic Awareness Day 2018
December 5 2018
Publication of the JPIAMR ERA-NET 2019 Call
February 18 2019 (11:00 CET)
Submission deadline for pre-proposals
Mid April 2019
Full proposal invitations sent to project coordinators
Update of the JPIAMR Strategic Research and Innovation Agenda 2018
The JPIAMR recognises that innovation is critically important in the field of AMR, as there is a strong need of new therapeutics, diagnostics, and innovative infection prevention and intervention measures. The JPIAMR is therefore currently refreshing its JPIAMR Strategic Research Agenda (SRA) to take account of recent research findings and to extend the JPIAMR SRA into a Strategic Research and Innovation Agenda (SRIA).
The research objectives and research priorities of the JPIAMR SRIA are now open for public consultation. We welcome feedback on the research topics from the AMR community from the 9th of July to the 15th of September (12.00 CET).
For more information and instructions for providing feedback, please click here.
We use first-party and third-party cookies. We do this so that the website works well and so that we can monitor how it is used. You can choose to turn off cookies in your browser.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
Installed by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
YouTube sets this cookie via embedded youtube-videos and registers anonymous statistical data.